Plant extracts: initial screening, identification of bioactive compounds and effect against Candida albicans biofilms

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Williams DW, Jordan RP, Wei XQ et al. Interactions of Candida albicans with host epithelial surfaces. J. Oral Microbiol. 5, 22434 (2013). •• Review to understand the molecular interactions between Candida albicans and the host.
  Google Scholar
• 2 Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect. Dis. 3(11), 685–702 (2003).
  MedlineGoogle Scholar
• 3 Deorukhkar SC, Saini S. Why Candida species have emerged as important nosocomial pathogens? Int. J. Curr. Microbiol. App. Sci. 5(1), 533–545 (2016).
  CASGoogle Scholar
• 4 Uppuluri P, Pierce CG, López-Ribot JL. Candida albicans biofilm formation and its clinical consequences. Future Microbiol. 4(10), 1235–1237 (2009).
  CASGoogle Scholar
• 5 Bujdáková H. Management of Candida biofilms: state of knowledge and new options for prevention and eradication. Future Microbiol. 11(2), 235–251 (2016). • Review of alternative therapies on C. albicans.
  CASGoogle Scholar
• 6 Girardot M, Imbert C. Novel strategies against Candida biofilms: interest of synthetic compounds. Future Microbiol. 11(1), 69–79 (2016). • Review of alternative therapies on C. albicans.
  CASGoogle Scholar
• 7 Kostov KG, Borges AC, Koga-Ito CY et al. Inactivation of Candida albicans by cold atmospheric pressure plasma jet. IEEE T. Plasma Sci. 43(3), 770–775 (2015).
  CASGoogle Scholar
• 8 Pfaller MA, Castanheira M, Messer SA et al. Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program. Diagn. Microbiol. Infect. Dis. 68(3), 278–283 (2010).
  MedlineGoogle Scholar
• 9 Lortholary O, Renaudat C, Sitbon K et al. Worrisome trends in incidence and mortality of candidemia in intensive care units. Intensive Care Med. 40(9), 1303–1312 (2014).
  MedlineGoogle Scholar
• 10 Leroy O, Bailly S, Gangneux JP et al. Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study. Ann. Intensive Care 6(1), 1–11 (2016).
  Medline CASGoogle Scholar
• 11 Alves CT, Ferreira ICFR, Barros L et al. Antifungal activity of phenolic compounds identified in flowers from North Eastern Portugal against Candida species. Future Microbiol. 9(2), 139–146 (2014).
  CASGoogle Scholar
• 12 Roque FO, Ochoa-Quintero J, Ribeiro DB et al. Upland habitat loss as a threat to Pantanal wetlands. Conserv. Biol. doi:10.1111/cobi.12713 (2016) (Epub ahead of print).
  MedlineGoogle Scholar
• 13 Dalmagro HJ, Lathuillière MJ, Vourlitis GL et al. Physiological responses to extreme hydrological events in the Pantanal wetland: heterogeneity of a plant community containing super-dominant species. J. Veg. Sci. 27(3), 568–577 (2016).
  Google Scholar
• 14 Brighenti FL, Salvador MJ, Delbem ACB et al. Systematic screening of plant extracts from the Brazilian Pantanal with antimicrobial activity against bacteria with cariogenic relevance. Caries Res. 48(5), 353–360 (2014).
  Medline CASGoogle Scholar
• 15 Teodoro GR, Brighenti FL, Delbem ACB et al. Antifungal activity of extracts and isolated compounds from Buchenavia tomentosa on Candida albicans and non-albicans. Future Microbiol. 10(6), 917–927 (2015).
  CASGoogle Scholar
• 16 Bruschi ML, Lara EHG, Martins CHG et al. Preparation and antimicrobial activity of gelatin microparticles containing propolis against oral pathogens. Drug Dev. Ind. Pharm. 32(2), 229–238 (2006).
  Medline CASGoogle Scholar
• 17 Salvador MJ, Ferreira EO, Pral EMF et al. Bioactivity of crude extracts and some constituents of Blutaparon portulacoides (Amaranthaceae). Phytomedicine 9(6), 566–571 (2002).
  Medline CASGoogle Scholar
• 18 Pascoal AC, Ehrenfried CA, Eberline MN et al. Free radical scavenging activity, determination of phenolic compounds and HPLC-DAD/ESI-MS profile of Campomanesia adamantium leaves. Nat. Prod. Commun. 6(7), 969–972 (2011).
  Medline CASGoogle Scholar
• 19 Sletten GBG, Dahl JE. Cytotoxic effects of extracts of compomers. Acta Odontol. Scand. 57(6), 316–322 (1999).
  Medline CASGoogle Scholar
• 20 Lagrou K, Peetermans WE, Jorissen M et al. Subinhibitory concentrations of erythromycin reduce pneumococcal adherence to respiratory epithelial cells in vitro. J. Antimicrob. Chemother. 46(5), 717–723 (2000).
  Medline CASGoogle Scholar
• 21 Di Bonaventura G, Spedicato I, D’Antonio D et al. Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. Antimicrob. Agents Chemother. 48(1), 151–160 (2004).
  Medline CASGoogle Scholar
• 22 Exterkate RAM, Crielaard W, Ten Cate JM. Different response to amine fluoride by Streptococcus mutans and polymicrobial biofilms in a novel high-throughput active attachment model. Caries Res. 44(4), 372–379 (2010).
  Medline CASGoogle Scholar
• 23 Brighenti FL, Luppens SBI, Delbem ACB et al. Effect of Psidium cattleianum leaf extract on Streptococcus mutans viability, protein expression and acid production. Caries Res. 42(2), 148–154 (2008).
  Medline CASGoogle Scholar
• 24 Dalle F, Wächtler B, L’Ollivier C et al. Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes. Cell. Microbiol. 12(2), 248–271 (2010).
  Medline CASGoogle Scholar
• 25 Weide MR, Ernst JF. Caco-2 monolayer as a model for transepithelial migration of the fungal pathogen Candida albicans. Mycoses 42(Suppl. 2), 61–67 (1999).
  MedlineGoogle Scholar
• 26 Frank CF, Hostetter MK. Cleavage of E-cadherin: a mechanism for disruption of the intestinal epithelial barrier by Candida albicans. Transl. Res. 149(4), 211–222 (2007).
  Medline CASGoogle Scholar
• 27 Murzyn A, Krasowska A, Augustyniak D et al. The effect of Saccharomyces boulardii on Candida albicans-infected human intestinal cell lines Caco-2 and Intestin 407. FEMS Microbiol. Lett. 310(1), 17–23 (2010).
  Medline CASGoogle Scholar
• 28 Jayatilake JA, Samaranayake YH, Samaranayake LP. An ultrastructural and a cytochemical study of candidal invasion of reconstituted human oral epithelium. J. Oral Pathol. Med. 34(4), 240–246 (2005).
  Medline CASGoogle Scholar
• 29 Tavares AC, Gonçalves MJ, Cavaleiro C et al. Essential oil of Daucus carota subsp. halophilus: composition, antifungal activity and cytotoxicity. J. Ethnopharmacol. 119(1), 129–134 (2008).
  Medline CASGoogle Scholar
• 30 Adnyana IK, Tezuka Y, Awale S et al. Quadranosides VI–XI, six new triterpene glucosides from the seeds of Combretum quadrangulare. Chem. Pharm. Bull. 48(8), 1114–1120 (2000).
  Medline CASGoogle Scholar
• 31 Batista A, Violante I, Garcez W et al. Phenolic compounds isolated from Buchenavia tomentosa Combretaceae. Presented at: 33a Reunião Anual da Sociedade Brasileira de Química, Águas de Lindóia, São Paulo, Brazil. 28–31 May 2010 (Abstract QPN-256).
  Google Scholar
• 32 Martini ND, Katerere DRP, Eloff JN. Biological activity of five antibacterial flavonoids from Combretum erythrophyllum (Combretaceae). J. Ethnopharmacol. 93(2), 207–212 (2004).
  Medline CASGoogle Scholar
• 33 Yang S-W, Zhou B-N, Wisse JH et al. Three new ellagic acid derivatives from the bark of Eschweilera coriacea from the Suriname rainforest 1. J. Nat. Prod. 61(7), 901–906 (1998).
  Medline CASGoogle Scholar
• 34 Pfaller MA, Wolk DM, Lowery TJ. T2MR and T2 Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis. Future Microbiol. 11(1), 103–117 (2016).
  CASGoogle Scholar
• 35 Silva IE Jr, Cechinel Filho V, Zacchino SA et al. Antimicrobial screening of some medicinal plants from Mato Grosso Cerrado. Rev. Bras. Farmacognosia 19, 242–248 (2009).
  Google Scholar
• 36 Matsubara VH, Wang Y, Bandara H, Mayer MP et al. Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation. Appl. Microbiol. Biotechnol. 100(14), 6415–6426 (2016).
  Medline CASGoogle Scholar
• 37 Harriott MM, Noverr MC. Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob. Agents Chemother. 53(9), 3914–3922 (2009).
  Medline CASGoogle Scholar
• 38 Fernandes RA, Monteiro DR, Arias LS et al. Biofilm formation by Candida albicans and Streptococcus mutans in the presence of farnesol: a quantitative evaluation. Biofouling 32(3), 329–338 (2016).
  Medline CASGoogle Scholar
• 39 Pinho E, Ferreira ICFR, Barros L et al. Antibacterial potential of northeastern Portugal wild plant extracts and respective phenolic compounds. BioMed Res. Int. 2014, 814590 (2014).
  MedlineGoogle Scholar
• 40 Jain PA, Mugeraya G, Srinikethan G et al. Studies on adhesion activity of Candida albicans to human buccal epithelial cells in relation to its growth phases. J. Biosci. Tech. 3(1), 449–454 (2012).
  Google Scholar
• 41 Seneviratne CJ, Silva WJ, Jin LJ et al. Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms. Arch. Oral Biol. 54(11), 1052–1060 (2009).
  Medline CASGoogle Scholar
• 42 Feldman M, Tanabe S, Howell A et al. Cranberry proanthocyanidins inhibit the adherence properties of Candida albicans and cytokine secretion by oral epithelial cells. BMC Complement. Altern. Med. 12(1), 1–12 (2012).
  Google Scholar
• 43 Abreu AC, Malheiro ABJ, Simões M. Resurgence of the interest in plants as sources of medicines and resistance-modifying agents. In: Microbial Pathogens and Strategies for Combating Them: Science, Technology and Education. Méndez-Vilas A (Eds). Formatex Research Center, Badajoz, Spain (2013).
  Google Scholar
• 44 Bala I, Bhardwaj V, Hariharan S et al. Analytical methods for assay of ellagic acid and its solubility studies. J. Pharm. Biomed. Anal. 40(1), 206–210 (2006).
  Medline CASGoogle Scholar
• 45 Abid Mehmood Yousaf OM, Kim DW, Kim DS et al. Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate. Int. J. Nanomedicine 12, 213 (2016).
  Google Scholar
• 46 Lestner JM, Howard SJ, Goodwin J et al. Pharmacokinetics and pharmacodynamics of amphotericin B deoxycholate, liposomal amphotericin B, and amphotericin B lipid complex in an in vitro model of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 54(8), 3432–3441 (2010). • Using an in vitro model inoculated with aspergillus for pharmacokinetic/pharmacodynamic study of drugs.
  Medline CASGoogle Scholar